A Randomized Phase 2 Study Of The Cyclin-Dependent Kinase (Cdk) Inhibitor Dinaciclib (Sch 727965) In Patients With Non-Small Cell Lung Cancer (Nsclc)Stephen L. Warren,John Nemunaitis,Joe Stephenson,Benoit Samson,Anil A. Joy,Da Zhang,Paul Statkevich,Ying-Ming Jou,Siu-Long Yao,Mark Navarro,Rajat Bannerji,Martin J. EdelmanCANCER RESEARCH(2011)引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要